Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

ASH 2024 Summary: Highlights in Adult ALL and Implications for Pract…

2024 ASH Annual Meeting Insights Hub

R. Cassaday

ASH 2024 Summary: Highlights in Ph- ALL

2024 ASH Annual Meeting Insights Hub

F. Haddad

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

Infectious Disease Perspective of CAR T-Cell Therapy

Moffitt Cancer Center

A. Baluch

Incorporation of Targeted and Immunotherapies in ALL

XV Eurasian Hematology-Oncology Congress - EHOC 2024

H. Kantarjian

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

2024 Review of Frontline Treatment in ALL

Louisville Hematology Highlights

N. Short

Treating Adult B-ALL: CAR-T vs. Bispecifics vs. Monoclonals

Marlise R. Luskin

Risk of Second Malignancies and T-Cell Lymphoma After CAR T-Cell The…

Stanford Medicine

M. Hamilton

Will Immune Therapy Replace Transplant in Hematologic Malignancies?

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. Gale

How Are Targeted Therapies Redefining the Treatment Paradigm in ALL …

SOHO Brazil 2024

J. Burger

2024 Updates on Understanding & Managing Immune Effector Cell Toxici…

Indy Hematology Review

D. Reeves

Transplantation in Adult ALL: Current Guidelines and Key Considerati…

ecancer

S. Tulpule

Frontline Treatment of ALL: Current Standards and Emergence of CAR-T

University of Colorado Cancer Center

M. Schwartz

Immunotherapy and Sequencing CD19-Targeted Therapies in Adults With …

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Jabbour

Infectious Complications in Pts Receiving CD19 vs. BCMA Targeted CAR…

Muhammad Abid

Clinically-Relevant Updates in ALL in Adults

Insights from 2023 ASH Annual Meeting

R. Cassaday

Bringing CAR-T for Hematologic Malignancies to the Community Practic…

James Essell